Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Factors associated with low cognitive performance in general practice

M J Dealberto1, B Sauron, C Derouesné

  • 1Institut National de la Santé et de la Recherche Médicale (INSERM), Unit 360, Villejuif, France.

European Archives of Psychiatry and Clinical Neuroscience
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Revue d'epidemiologie et de sante publique·2019
Same author

Revue d'epidemiologie et de sante publique·2017
Same author

A genome-wide association meta-analysis of plasma Aβ peptides concentrations in the elderly.

Molecular psychiatry·2014
Same author

Impact of allopurinol on risk of myocardial infarction.

Annals of the rheumatic diseases·2014
Same author

Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease.

Molecular psychiatry·2012
Same author

Therapeutic approaches to age-associated neurocognitive disorders.

Dialogues in clinical neuroscience·2011

Antihypertensive medication and psychotropic drug use were linked to lower cognitive function test results in adults aged 45-75. These factors, particularly psychotropic drug use, significantly impact cognitive decline studies in aging populations.

Area of Science:

  • Neuroscience
  • Gerontology
  • Pharmacology

Background:

  • Cognitive decline is a significant concern in aging populations.
  • Understanding factors influencing cognitive function is crucial for early intervention.
  • Longitudinal studies require careful consideration of medication effects.

Purpose of the Study:

  • To investigate the association between antihypertensive medication, psychotropic drug use, and cognitive function in adults aged 45-75.
  • To assess the impact of these medications on immediate recall, delayed memory, and attention.
  • To inform the design of future longitudinal studies on cognitive aging.

Main Methods:

  • A preparatory phase of a randomized controlled trial involving 1628 volunteers (age 45-75).
  • Administration of a neuropsychological test battery assessing immediate recall, delayed memory, and attention.

Related Experiment Videos

  • Analysis of cognitive test results in relation to antihypertensive medication and psychotropic drug use.

    • Main Results:

    • Antihypertensive medication use was associated with lower scores on all cognitive tests across all age groups and blood pressure strata.
    • Psychotropic drug use also correlated with lower cognitive test performance.
    • The performance gap between psychotropic drug users and non-users widened with increasing age.

    Conclusions:

    • Antihypertensive treatment and psychotropic drug use are significant factors to consider in studies of cognitive decline in aging.
    • These medications may influence cognitive function trajectories, necessitating their inclusion as covariates in research.
    • Further research is warranted to explore the mechanisms behind these associations.